Comparison of two marketed effervescent fast relief formulations for antacid activity-an in vitro study

Pranjali P. Dhawal, Siddhivinayak S. Barve, Dyotona Sen-Roy


Background: Hyper-acidity is excessive formation of acid (pH=1.5-3.5) in the stomach by parietal cells which causes a burning sensation in the chest. The preservation of gastric acid insult is crucial because of the implications of hyperacidity in gastroesophageal reflux disease (GERD), peptic ulcers and duodenal ulcers. Acidity is controlled by use of some over-the-counter (OTC) antacid formulations containing magnesium or aluminum hydroxides.

Methods: In the present study, the preliminary antacid test (PAT), the pH acid neutralizing capacity (ANC), acid neutralizing potential (ANP) along with buffering capacity of two well-known quick release formulations (F1 [Digene Ultra Fizz] and F2 [a standard, commercially available product]) were determined.

Results: According to US pharmacopeia USP, both the antacid formulations passed the PAT test. PAT results revealed that the pH of the acid-antacid solution was higher in F1 (8.20±0.02) as compared to F2, (6.53±0.01). The ANC results revealed that F1 (46.89±0.6 mEq/dosage) had higher neutralizing capacity as compared to F2(30.12±1.3 mEq/dosage). Higher ANP was observed for F1 (245 mins), and it was 2.7 times that of F2 (90 min). The onset of action for both the antacids was <2 seconds. Additionally, buffering capacity was evidently observed during ANP analysis in the case of F1. Independent T test performed for all the tests revealed that the data obtained was highly significant (p<0.01).

Conclusions: F1 showed high antacid and buffering properties when tested in vitro. The present study highlights the need for future research on specific OTC non-prescribed antacid formulations with respect to their price, efficacy and side effects.


Acid neutralizing capacity, Acid neutralizing potential, Preliminary antacid test

Full Text:



Panda VS, Shinde PM. A comparative study of the antacid effect of raw spinach juice and spinach extract in an artificial stomach model. J Complementary Integrative Med. 2016;13(4):387-91.

Wallace J. Recent advances in gastric ulcer therapeutics. Current Opinion Pharmacol. 2005;5(6):573-7.

Jagadesh K. Study of Acid Neutralizing Capacity of Various Antacid Formulations. Asian J Pharmac Technol Innovation. 2015;3(12):113-20.

Rana V, Mishra A, Mehra BL. Evaluation of efficacy and safety of Gas-O-Fast (Ajwain) in Amalpitta. Int J Ayurvedic Med. 2017;1;8(3):138-42.

Johnson SM, Suralik J. A Comparison of the Effect of Regular F2® and Placebo on Intragastric pH. Practical Gastroenterol. 2009;28-32.

Dhawal PP, Barve SS. Preliminary invitro evaluation of marketed formulations for antacid activity. Int J Basic Clin Pharmacol. 2020;9(1):57-62.

De Souza NE, Godinho OE, Aleixo LM. Procedure for the simultaneous determination of tartaric and citric acids and total carbonate by potentiometric titrimetric and its application to antacid analysis. Analyst. 1985;110(8):989-91.

Khandare B, Bhujbal N. In-vitro Gastric acid percent neutralizing potential of household remedies verses marketed antacid preparation: A case report. J Drug Delivery Therap. 2019;9(4-s):595-7.

Brody M, Bachrach WH. Antacids I. Comparative biochemical and economic considerations. Am j digestive dis. 1959;4(6):435-60.

Thimmaraju MK, Bheemanapally K, Rao JV, Rao KS, Nerella R. Quantitative determination of Cimetidine in both bulk and formulations using neutralization titrations. J Appl Pharma Sci. 2012;2(1):119.

Suvarna I, Kumari A, Jeenal P, Tejas P, Pramod I. Biological standardization of some polyherbal formulations for antacid activity. 2014;6(1):83-6.

Malviya R, Pant S, Sharma PK. Evaluation of Acid Nuetralising Capacity of Marketed Digene Tablet tm. Global J Pharmacol. 2015;9(1):64-6.

Richa A, Kadam HM, Kadam SS, Paradkar AR. Studies on shankhabhasma-I antacid activity evaluation of ShankhaBhasma. Indian pharmace sci. 1997;59(5):254.

Lirazan M, Cua SJ, Alvarez MR. Invitro Antacid Screening of the Aqueous and Ethanolic Leaf extracts of Triticumaestivum (Linn.) and Hordeumvulgare (Linn.). Oriental J Chem. 2018;34(1):93.

Vedavathi H, Tejasvi TS, Shreenivas PR. Evaluation of cost effectiveness and efficacy of commonly used different antacid gel preparations. Int J Basic Clin Pharmacol. 2013;(6):788-91.

Martin G. Rating Antacids in Consumer Reports. Symposium on Critical Thinking and Consumer.Chemistry. 1986:214-6.

Lin MS, Sun P, Yu HY. Evaluation of buffering capacity and acid neutralizing-pH time profile of antacids. Journal of the Formosan Medical Association Taiwan yizhi. 1998;97(10):704-10.

Manoj VJ, Vaibhav GN, Vaibhav NR, Gaikwad DD, Jadhav SJ. Formulation Development and Evaluation of Rapidly Disintegrating Antacid Tablets. Int J Recent Sci Res 2016;7(10):13802-6.

Rosset NF, Rice ML Jr. An in vitro evaluation of the efficacy of the more frequently used antacids with particular attention to tablets. Gastroenterol. 1954;26(3):490-5.

Katakam P, Rajab J. A Comparative Study of the Acid Neutralizing Capacity of Various Commercially Available Antacid Formulations in Libya. Libyan J Med Res. 2010;7(1):41-9.

Ayensu I, Bekoe SO, Adu JK, Brobbey AA, Appiah E. Evaluation of Acid Neutralising and Buffering Capacities of Selected Antacids In Ghana. Sci Afr. 2020;8(2020):00347.

Mahmood D, Alnaseer S, Muhammad BY, Khalilullah H, Abdulghani MA, Anwar MJ, Alenezi SK, Haider M, Elleban N. Acid-neutralising capacity and pharmacoeconomic studies of commercially available antacids in the Qassim Region of Saudi Arabia. Hamdan Med J. 2020;13(3):150-5.

Brody M, Bachrach WH. Antacids I. Comparative biochemical and economic considerations. Am j Digest Dis. 1959;4(6):435-60.